交易 Abbott Laboratories - ABT CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.23 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Abbott Laboratories ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 5, 2023 | 103.67 | -0.24 | -0.23% | 103.91 | 104.90 | 103.21 |
Jun 2, 2023 | 104.12 | 1.18 | 1.15% | 102.94 | 104.43 | 102.65 |
Jun 1, 2023 | 102.71 | 1.41 | 1.39% | 101.30 | 102.84 | 100.41 |
May 31, 2023 | 101.89 | 0.79 | 0.78% | 101.10 | 102.13 | 100.26 |
May 30, 2023 | 101.62 | -0.32 | -0.31% | 101.94 | 102.45 | 101.29 |
May 26, 2023 | 102.79 | 0.80 | 0.78% | 101.99 | 103.38 | 101.43 |
May 25, 2023 | 102.04 | -0.75 | -0.73% | 102.79 | 103.24 | 101.17 |
May 24, 2023 | 103.95 | -1.50 | -1.42% | 105.45 | 105.45 | 103.87 |
May 23, 2023 | 105.62 | -1.41 | -1.32% | 107.03 | 107.40 | 105.35 |
May 22, 2023 | 108.13 | 0.15 | 0.14% | 107.98 | 109.24 | 107.92 |
May 19, 2023 | 108.81 | 0.93 | 0.86% | 107.88 | 109.88 | 107.88 |
May 18, 2023 | 108.40 | 0.38 | 0.35% | 108.02 | 108.76 | 107.54 |
May 17, 2023 | 108.69 | -1.06 | -0.97% | 109.75 | 109.81 | 107.72 |
May 16, 2023 | 109.28 | 0.52 | 0.48% | 108.76 | 110.37 | 108.71 |
May 15, 2023 | 109.72 | -0.32 | -0.29% | 110.04 | 110.82 | 109.32 |
May 12, 2023 | 110.36 | 1.14 | 1.04% | 109.22 | 110.46 | 109.12 |
May 11, 2023 | 109.92 | -0.15 | -0.14% | 110.07 | 110.31 | 109.16 |
May 10, 2023 | 110.60 | 0.42 | 0.38% | 110.18 | 110.87 | 109.48 |
May 9, 2023 | 110.17 | 0.71 | 0.65% | 109.46 | 110.95 | 109.10 |
May 8, 2023 | 110.78 | 0.42 | 0.38% | 110.36 | 111.50 | 109.79 |
Abbott Laboratories Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Tuesday, July 18, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家/地区 US
| 事件 Q2 2023 Abbott Laboratories Earnings Release Q2 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
Tuesday, October 17, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家/地区 US
| 事件 Q3 2023 Abbott Laboratories Earnings Release Q3 2023 Abbott Laboratories Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 43653 | 43075 | 34608 | 31904 | 30578 |
收入 | 43653 | 43075 | 34608 | 31904 | 30578 |
收入成本,共计 | 19083 | 18490 | 14967 | 13196 | 12691 |
毛利 | 24570 | 24585 | 19641 | 18708 | 17887 |
总营业费用 | 35336 | 34650 | 29136 | 27435 | 27095 |
销售/一般/行政费用,总计 | 11109 | 11217 | 9676 | 9694 | 9691 |
研究与开发 | 2741 | 2733 | 2403 | 2408 | 2288 |
Depreciation / Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
异常费用(收入) | 390 | 163 | -42 | 201 | 247 |
营业收入 | 8317 | 8425 | 5472 | 4469 | 3483 |
利息收入(费用),非经营净值 | -377 | -491 | -492 | -583 | -749 |
其他,净值 | 366 | 277 | -12 | 191 | 139 |
税前净收入 | 8306 | 8211 | 4968 | 4077 | 2873 |
税后净收入 | 6933 | 7071 | 4497 | 3601 | 2464 |
未计算非常项目前的净收益 | 6933 | 7071 | 4497 | 3601 | 2464 |
非常规项目总计 | 0 | -2 | 86 | -96 | |
净收入 | 6933 | 7071 | 4495 | 3687 | 2368 |
普通股股东可获收益 (不含非经常性项目) | 6933 | 7071 | 4497 | 3601 | 2464 |
普通股股东可获收益 (含非經常性項目) | 6933 | 7071 | 4495 | 3687 | 2368 |
摊薄净收入 | 6933 | 7071 | 4495 | 3687 | 2368 |
摊薄后加权平均股 | 1764 | 1789 | 1786 | 1781 | 1770 |
扣除特别项目的每股摊薄盈利 | 3.93027 | 3.95249 | 2.51792 | 2.0219 | 1.39209 |
Dividends per Share - Common Stock Primary Issue | 1.88 | 1.8 | 1.44 | 1.28 | 1.12 |
每股正常摊薄盈利 | 4.11623 | 4.03095 | 2.49663 | 2.12158 | 1.51177 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 9747 | 10091 | 10410 | 11257 | 11895 |
收入 | 9747 | 10091 | 10410 | 11257 | 11895 |
收入成本,共计 | 4325 | 4593 | 4629 | 4933 | 4987 |
毛利 | 5422 | 5498 | 5781 | 6324 | 6908 |
总营业费用 | 8238 | 8787 | 8640 | 8881 | 8983 |
销售/一般/行政费用,总计 | 2751 | 2973 | 2731 | 2757 | 2787 |
研究与开发 | 654 | 725 | 671 | 684 | 697 |
Depreciation / Amortization | 491 | 496 | 498 | 507 | 512 |
异常费用(收入) | 17 | 0 | 111 | ||
营业收入 | 1509 | 1304 | 1770 | 2376 | 2912 |
利息收入(费用),非经营净值 | -58 | -52 | -105 | -106 | -114 |
其他,净值 | 111 | 68 | 93 | 82 | 78 |
税前净收入 | 1562 | 1320 | 1758 | 2352 | 2876 |
税后净收入 | 1318 | 1033 | 1435 | 2018 | 2447 |
未计算非常项目前的净收益 | 1318 | 1033 | 1435 | 2018 | 2447 |
非常规项目总计 | |||||
净收入 | 1318 | 1033 | 1435 | 2018 | 2447 |
普通股股东可获收益 (不含非经常性项目) | 1318 | 1033 | 1435 | 2018 | 2447 |
普通股股东可获收益 (含非經常性項目) | 1318 | 1033 | 1435 | 2018 | 2447 |
摊薄净收入 | 1318 | 1033 | 1435 | 2018 | 2447 |
摊薄后加权平均股 | 1751.71 | 1752.46 | 1763.65 | 1765.46 | 1774.54 |
扣除特别项目的每股摊薄盈利 | 0.75241 | 0.58946 | 0.81365 | 1.14304 | 1.37895 |
Dividends per Share - Common Stock Primary Issue | 0.51 | 0.47 | 0.47 | 0.47 | 0.47 |
每股正常摊薄盈利 | 0.76059 | 0.58946 | 0.86503 | 1.14304 | 1.37895 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 25224 | 24239 | 20441 | 15667 | 14632 |
现金和短期投资 | 10170 | 10249 | 7148 | 4140 | 4086 |
现金等价物 | 9882 | 9799 | 6838 | 3860 | 3844 |
短期投资 | 288 | 450 | 310 | 280 | 242 |
应收账款总额,净额 | 6218 | 6487 | 6414 | 5425 | 5182 |
Accounts Receivable - Trade, Net | 6218 | 6487 | 6414 | 5425 | 5182 |
Total Inventory | 6173 | 5157 | 5012 | 4316 | 3796 |
Prepaid Expenses | 2663 | 2346 | 1867 | 1638 | 1445 |
Other Current Assets, Total | 148 | 123 | |||
Total Assets | 74438 | 75196 | 72548 | 67887 | 67173 |
Property/Plant/Equipment, Total - Net | 10278 | 10112 | 10130 | 8972 | 7563 |
Property/Plant/Equipment, Total - Gross | 21328 | 20517 | 19894 | 17733 | 15706 |
Accumulated Depreciation, Total | -11050 | -10405 | -9764 | -8761 | -8143 |
Goodwill, Net | 22799 | 23231 | 23744 | 23195 | 23254 |
Intangibles, Net | 10454 | 12739 | 14784 | 17025 | 18942 |
Long Term Investments | 766 | 816 | 821 | 883 | 897 |
Other Long Term Assets, Total | 4917 | 4059 | 2628 | 2145 | 1885 |
Total Current Liabilities | 15489 | 13105 | 11907 | 10863 | 9012 |
Accounts Payable | 4607 | 4408 | 3946 | 3252 | 2975 |
Accrued Expenses | 7401 | 6806 | 6581 | 5183 | 4867 |
Notes Payable/Short Term Debt | 0 | 0 | 213 | 201 | 200 |
Current Port. of LT Debt/Capital Leases | 2251 | 754 | 7 | 1277 | 7 |
Other Current Liabilities, Total | 1230 | 1137 | 1160 | 950 | 963 |
Total Liabilities | 37752 | 39394 | 39764 | 36799 | 36649 |
Total Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
Long Term Debt | 14522 | 17296 | 18527 | 16115 | 19359 |
Deferred Income Tax | 991 | 1392 | 1406 | 1546 | 2056 |
Minority Interest | 219 | 222 | 219 | 213 | 198 |
Other Liabilities, Total | 6531 | 7379 | 7705 | 8062 | 6024 |
Total Equity | 36686 | 35802 | 32784 | 31088 | 30524 |
Common Stock | 24709 | 24470 | 24145 | 23853 | 23512 |
Retained Earnings (Accumulated Deficit) | 35257 | 31528 | 27627 | 25847 | 24560 |
Treasury Stock - Common | -15229 | -11822 | -10042 | -10147 | -9962 |
Unrealized Gain (Loss) | 0 | 0 | |||
Other Equity, Total | -8051 | -8374 | -8946 | -8465 | -7586 |
Total Liabilities & Shareholders’ Equity | 74438 | 75196 | 72548 | 67887 | 67173 |
Total Common Shares Outstanding | 1737.8 | 1764.08 | 1771.23 | 1762.5 | 1755.62 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 24377 | 25224 | 24845 | 24956 | 23429 |
现金和短期投资 | 9532 | 10170 | 9907 | 9290 | 8158 |
现金等价物 | 9161 | 9882 | 9594 | 8937 | 7675 |
短期投资 | 371 | 288 | 313 | 353 | 483 |
应收账款总额,净额 | 6020 | 6218 | 6408 | 7199 | 7179 |
Accounts Receivable - Trade, Net | 6020 | 6218 | 6408 | 7199 | 7179 |
Total Inventory | 6673 | 6173 | 5734 | 5899 | 5691 |
Prepaid Expenses | 2152 | 2663 | 2796 | 2568 | 2401 |
Total Assets | 73794 | 74438 | 72801 | 74202 | 74007 |
Property/Plant/Equipment, Total - Net | 9282 | 9162 | 8689 | 8818 | 8908 |
Property/Plant/Equipment, Total - Gross | 20605 | 20212 | 19306 | 19458 | 19521 |
Accumulated Depreciation, Total | -11323 | -11050 | -10617 | -10640 | -10613 |
Goodwill, Net | 22927 | 22799 | 22284 | 22744 | 23179 |
Intangibles, Net | 10006 | 10454 | 10850 | 11592 | 12225 |
Long Term Investments | 776 | 766 | 764 | 734 | 763 |
Other Long Term Assets, Total | 6426 | 6033 | 5369 | 5358 | 5503 |
Total Current Liabilities | 14530 | 15489 | 13365 | 12392 | 12647 |
Accounts Payable | 4167 | 4607 | 4133 | 4493 | 4757 |
Accrued Expenses | 6856 | 7401 | 6901 | 6715 | 6724 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2285 | 2251 | 1117 | 5 | 4 |
Other Current Liabilities, Total | 1222 | 1230 | 1214 | 1179 | 1162 |
Total Liabilities | 36784 | 37752 | 37126 | 37712 | 38608 |
Total Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
Long Term Debt | 14615 | 14522 | 15297 | 16755 | 17086 |
Minority Interest | 222 | 219 | 209 | 226 | 230 |
Other Liabilities, Total | 7417 | 7522 | 8255 | 8339 | 8645 |
Total Equity | 37010 | 36686 | 35675 | 36490 | 35399 |
Common Stock | 24488 | 24709 | 24560 | 24429 | 24304 |
Retained Earnings (Accumulated Deficit) | 35868 | 35257 | 35115 | 34487 | 33295 |
Treasury Stock - Common | -15307 | -15229 | -14555 | -13720 | -13726 |
Other Equity, Total | -8039 | -8051 | -9445 | -8706 | -8474 |
Total Liabilities & Shareholders’ Equity | 73794 | 74438 | 72801 | 74202 | 74007 |
Total Common Shares Outstanding | 1738.95 | 1737.8 | 1743.57 | 1751.22 | 1750.94 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 6933 | 7071 | 4495 | 3687 | 2368 |
经营活动产生的现金 | 9581 | 10533 | 7901 | 6136 | 6300 |
经营活动产生的现金 | 1254 | 1491 | 1195 | 1078 | 1100 |
Amortization | 2013 | 2047 | 2132 | 1936 | 2178 |
非现金物品 | 900 | 695 | 971 | 766 | 802 |
Cash Taxes Paid | 1864 | 1941 | 970 | 930 | 740 |
已付现金利息 | 563 | 544 | 549 | 677 | 845 |
营运资金的变化 | -1519 | -771 | -892 | -1331 | -148 |
投资活动产生的现金 | -1740 | -2008 | -2215 | -1815 | -1356 |
资本支出 | -1777 | -1885 | -2177 | -1638 | -1394 |
其他投资现金流量项目,总计 | 37 | -123 | -38 | -177 | 38 |
融资活动产生的现金 | -7636 | -5494 | -2779 | -4289 | -10391 |
融资现金流项目 | 0 | -11 | 0 | 0 | |
Total Cash Dividends Paid | -3309 | -3202 | -2560 | -2270 | -1974 |
股票的发行(报废),净额 | -3628 | -2044 | -158 | -420 | 33 |
债务的发行(退还),净额 | -699 | -248 | -50 | -1599 | -8450 |
外汇效应 | -122 | -70 | 71 | -16 | -116 |
现金净变化 | 83 | 2961 | 2978 | 16 | -5563 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1318 | 6933 | 5900 | 4465 | 2447 |
Cash From Operating Activities | 1143 | 9581 | 7255 | 4475 | 2065 |
Cash From Operating Activities | 315 | 1254 | 943 | 626 | 311 |
Amortization | 491 | 2013 | 1517 | 1019 | 512 |
Non-Cash Items | 281 | 900 | 570 | 447 | 305 |
Changes in Working Capital | -1262 | -1519 | -1675 | -2082 | -1510 |
Cash From Investing Activities | -462 | -1740 | -1108 | -624 | -360 |
Capital Expenditures | -380 | -1777 | -1167 | -700 | -321 |
Other Investing Cash Flow Items, Total | -82 | 37 | 59 | 76 | -39 |
Cash From Financing Activities | -1410 | -7636 | -6179 | -4636 | -3823 |
Total Cash Dividends Paid | -890 | -3309 | -2486 | -1660 | -832 |
Issuance (Retirement) of Stock, Net | -478 | -3628 | -2984 | -2243 | -2248 |
Issuance (Retirement) of Debt, Net | -42 | -699 | -709 | -733 | -743 |
Foreign Exchange Effects | 8 | -122 | -173 | -77 | -6 |
Net Change in Cash | -721 | 83 | -205 | -862 | -2124 |
Financing Cash Flow Items |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.9022 | 154804032 | 140826 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0365 | 87581226 | -1284956 | 2023-03-31 | LOW |
Capital Research Global Investors | Investment Advisor | 4.3937 | 76404889 | -380473 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2241 | 73454220 | -1157666 | 2023-03-31 | LOW |
Capital International Investors | Investment Advisor | 3.2451 | 56430955 | 3405170 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.794 | 31196788 | 598164 | 2023-03-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.1973 | 20820152 | 6003997 | 2023-03-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.1714 | 20370034 | -3516448 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9919 | 17248522 | 765489 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.8721 | 15165569 | 261719 | 2023-03-31 | LOW |
Morgan Stanley Investment Management Ltd. (UK) | Investment Advisor | 0.8674 | 15083595 | -202533 | 2023-03-31 | LOW |
BofA Global Research (US) | Research Firm | 0.821 | 14276700 | 229604 | 2023-03-31 | LOW |
Polen Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8194 | 14249447 | -369295 | 2023-03-31 | LOW |
State Farm Insurance Companies | Insurance Company | 0.7813 | 13587118 | 0 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7577 | 13176421 | -145790 | 2023-03-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7087 | 12324688 | 44918 | 2023-03-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6984 | 12144038 | 54953 | 2023-03-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.69 | 11998117 | -283807 | 2023-03-31 | LOW |
UBS Asset Management (Americas), Inc. | Investment Advisor | 0.6618 | 11509019 | 8668200 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 0.6085 | 10582312 | 377456 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Abbott Company profile
关于 Abbott Laboratories
雅培实验室从事发现、开发、制造和销售多样化的医疗保健产品。 公司通过四个部门运营。 既定的医药产品、诊断产品、营养产品和医疗设备。 其成熟的医药产品部门包括胃肠病产品、妇女健康产品、心血管和代谢产品、疼痛和中枢神经系统产品以及呼吸系统药物和疫苗。 其诊断产品部门包括免疫测定、临床化学、血液学和输血医学领域的核心实验室系统;分子诊断聚合酶链反应(PCR)仪器系统;护理点系统;快速诊断横向流动测试产品,以及信息学和自动化解决方案。 其营养产品部门包括各种形式的婴儿配方奶粉和后续配方奶粉、成人和其他儿科营养产品及其他。
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Abbott Park Rd
ABBOTT PARK
ILLINOIS 60064-3500
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。